Q2 2019 13F Holders as of 6/30/2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
226M
-
Number of holders
-
1005
-
Total 13F shares, excl. options
-
228M
-
Shares change
-
+8.04M
-
Total reported value, excl. options
-
$64.1B
-
Value change
-
+$2.25B
-
Put/Call ratio
-
0.83
-
Number of buys
-
477
-
Number of sells
-
-490
-
Price
-
$282.21
Significant Holders of Elevance Health, Inc. - Common Stock (ELV) as of Q2 2019
1,198 filings reported holding ELV - Elevance Health, Inc. - Common Stock as of Q2 2019.
Elevance Health, Inc. - Common Stock (ELV) has 1,005 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 228M shares
.
Largest 10 shareholders include BlackRock Inc. (22.7M shares), VANGUARD GROUP INC (19.5M shares), PRICE T ROWE ASSOCIATES INC /MD/ (17M shares), STATE STREET CORP (11.2M shares), FMR LLC (9.52M shares), WELLINGTON MANAGEMENT GROUP LLP (8.05M shares), Invesco Ltd. (5.67M shares), Viking Global Investors LP (5.2M shares), BAILLIE GIFFORD & CO (4.41M shares), and BARROW HANLEY MEWHINNEY & STRAUSS LLC (3.82M shares).
This table shows the top 1005 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.